Loading…

Appraisal of intratumoral microvessel density, MIB‐1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma

BACKGROUND The prognostic values of intratumoral microvessel density (iMVD), tumor cell proliferation rate, DNA content (ploidy), and p53 protein expression are controversial or have not been well studied in patients with renal cell carcinoma (RCC) confined to the kidney. METHODS A uniform group of...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1997-11, Vol.80 (9), p.1768-1775
Main Authors: Gelb, Arnold B., Sudilovsky, Daniel, Wu, C. Daniel, Weiss, Lawrence M., Medeiros, L. Jeffrey
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c4821-6c2497fab7826885538c5803068b4de5f74a23fcea13ef360658aefe72a6aac63
container_end_page 1775
container_issue 9
container_start_page 1768
container_title Cancer
container_volume 80
creator Gelb, Arnold B.
Sudilovsky, Daniel
Wu, C. Daniel
Weiss, Lawrence M.
Medeiros, L. Jeffrey
description BACKGROUND The prognostic values of intratumoral microvessel density (iMVD), tumor cell proliferation rate, DNA content (ploidy), and p53 protein expression are controversial or have not been well studied in patients with renal cell carcinoma (RCC) confined to the kidney. METHODS A uniform group of 52 clear cell (conventional) RCCs confined to the kidney (classified as T1N0M0 or T2N0M0) were analyzed for iMVD, MIB‐1 score, DNA content, S‐phase fraction, and p53 protein expression by immunohistochemical methods or flow cytometry. iMVD was evaluated in a single area (X200, 1.15 mm2) representative of the highest MVD (neovascular "hot spot") after independently highlighting endothelial cells with antibodies specific for factor VIII‐related antigen (F8/86) and CD31 (JC/70A). The MIB‐1 antibody (Ki‐67 antigen) score was used as a marker for the tumor cell proliferation rate. DNA content and S‐phase fraction were determined by flow cytometry using paraffin embedded tissue. p53 expression was assessed using the D07 antibody. RESULTS The median time of clinical follow‐up was > 9 years. Eleven patients died of disease; the median time to death was 26 months. iMVD counts using antifactor VIII and anti‐CD31 were tightly correlated (correlation coefficient = 0.89). S‐phase fraction was higher in aneuploid tumors than in diploid tumors (mean, 12.4% vs. 4.3%; P = 0.01). Using univariate survival analyses, tumor size (stage classification pT1 vs. PT2; P = 0.01) and nuclear grade (P = 0.04) were associated with shortened survival. No statistically significant differences in survival were found for iMVD, MIB‐1 score, DNA content, S‐phase fraction, or p53 expression. Only two cases strongly expressed p53 protein; both tumors were of high nuclear grade. Using multivariate survival analyses, nuclear grade and tumor size were the only independent prognostic factors (best model P = 0.002). CONCLUSIONS In this study, nuclear grade and tumor size were found to be independent predictors of survival in locally confined clear cell (conventional) RCC, as has been shown previously for locally confined RCC in general. MIB‐1 score, iMVD counts, DNA content, S‐phase fraction, and p53 expression did not contribute additional prognostic information. Cancer 1997; 80:1768‐75. © 1997 American Cancer Society. In a series of 52 clear cell renal cell carcinomas confined to the kidney (classified as pT1N0M0 or pT2N0M0), intratumoral microvessel density, MIB‐1 (Ki‐67) score, S‐phase fraction, DNA
doi_str_mv 10.1002/(SICI)1097-0142(19971101)80:9<1768::AID-CNCR11>3.0.CO;2-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79370951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79370951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4821-6c2497fab7826885538c5803068b4de5f74a23fcea13ef360658aefe72a6aac63</originalsourceid><addsrcrecordid>eNqFkd2KEzEUxwdR1rr6CEIuRHahU_MxmWSqCN1ZPwrrFvwAxYuQZjIamUlmk9S1dz6CL-ML-SRmaO2NgjdJzjn_c_Ln_LJsgeAMQYgfnbxZ1stTBCuWQ1TgE1RVDCGITjmcV08QK_l8vlie5_Vl_Rqhp2QGZ_XqMc7JjWxy6LqZTSCEPKcFeX87uxPClxQyTMlRdlQRimhRTrKfi2Hw0gTZAdcCY6OXcdM7n-LeKO--6hB0Bxptg4nbKXi1PPv1_QcCQTmvp-D8cgGUs1HbOAXSNmCgBAzeRW0s0N8Gn9qNs0CGMfvJuhCNSt80RsnofEhPMMhoUn8A1yZ-Bp1Tsuu249TWWN0Ar20yo3SXDumVsa6Xd7NbreyCvre_j7N3z5-9rV_mF6sXy3pxkauCY5SXChcVa-WacVxyTinhinJIYMnXRaNpywqJSau0RES3pIQl5VK3mmFZSqlKcpw93M1N5q82OkTRmzBakVa7TRCsIgxWFCXhh50wrSwEr1sxeNNLvxUIihGpECNSMcIRIxzxB6ngUFRiRCpEQip2SAURUNQrgQVJs-_vTWzWvW4Ok_cMU_3Bvi5D2l3rpVUmHGQYlgVnMMk-7mTXptPbv_z9394_3e0z5Dc0N847</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79370951</pqid></control><display><type>article</type><title>Appraisal of intratumoral microvessel density, MIB‐1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>EZB Electronic Journals Library</source><creator>Gelb, Arnold B. ; Sudilovsky, Daniel ; Wu, C. Daniel ; Weiss, Lawrence M. ; Medeiros, L. Jeffrey</creator><creatorcontrib>Gelb, Arnold B. ; Sudilovsky, Daniel ; Wu, C. Daniel ; Weiss, Lawrence M. ; Medeiros, L. Jeffrey</creatorcontrib><description>BACKGROUND The prognostic values of intratumoral microvessel density (iMVD), tumor cell proliferation rate, DNA content (ploidy), and p53 protein expression are controversial or have not been well studied in patients with renal cell carcinoma (RCC) confined to the kidney. METHODS A uniform group of 52 clear cell (conventional) RCCs confined to the kidney (classified as T1N0M0 or T2N0M0) were analyzed for iMVD, MIB‐1 score, DNA content, S‐phase fraction, and p53 protein expression by immunohistochemical methods or flow cytometry. iMVD was evaluated in a single area (X200, 1.15 mm2) representative of the highest MVD (neovascular "hot spot") after independently highlighting endothelial cells with antibodies specific for factor VIII‐related antigen (F8/86) and CD31 (JC/70A). The MIB‐1 antibody (Ki‐67 antigen) score was used as a marker for the tumor cell proliferation rate. DNA content and S‐phase fraction were determined by flow cytometry using paraffin embedded tissue. p53 expression was assessed using the D07 antibody. RESULTS The median time of clinical follow‐up was &gt; 9 years. Eleven patients died of disease; the median time to death was 26 months. iMVD counts using antifactor VIII and anti‐CD31 were tightly correlated (correlation coefficient = 0.89). S‐phase fraction was higher in aneuploid tumors than in diploid tumors (mean, 12.4% vs. 4.3%; P = 0.01). Using univariate survival analyses, tumor size (stage classification pT1 vs. PT2; P = 0.01) and nuclear grade (P = 0.04) were associated with shortened survival. No statistically significant differences in survival were found for iMVD, MIB‐1 score, DNA content, S‐phase fraction, or p53 expression. Only two cases strongly expressed p53 protein; both tumors were of high nuclear grade. Using multivariate survival analyses, nuclear grade and tumor size were the only independent prognostic factors (best model P = 0.002). CONCLUSIONS In this study, nuclear grade and tumor size were found to be independent predictors of survival in locally confined clear cell (conventional) RCC, as has been shown previously for locally confined RCC in general. MIB‐1 score, iMVD counts, DNA content, S‐phase fraction, and p53 expression did not contribute additional prognostic information. Cancer 1997; 80:1768‐75. © 1997 American Cancer Society. In a series of 52 clear cell renal cell carcinomas confined to the kidney (classified as pT1N0M0 or pT2N0M0), intratumoral microvessel density, MIB‐1 (Ki‐67) score, S‐phase fraction, DNA content (ploidy), and p53 protein expression did not contribute additional prognostic information. Size (stage classification pT1 vs. pT2) and nuclear grade were found to be the best predictors of survival.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/(SICI)1097-0142(19971101)80:9&lt;1768::AID-CNCR11&gt;3.0.CO;2-3</identifier><identifier>PMID: 9351546</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; Aged ; Antigens, Nuclear ; Biological and medical sciences ; Biomarkers, Tumor - analysis ; Carcinoma, Renal Cell - blood supply ; Carcinoma, Renal Cell - diagnosis ; Cell Division ; DNA content ; DNA, Neoplasm - metabolism ; Female ; Flow Cytometry ; Follow-Up Studies ; Humans ; Immunohistochemistry ; intratumoral microvessel density ; Ki-67 Antigen ; Kidney ; Kidney Neoplasms - blood supply ; Kidney Neoplasms - diagnosis ; Kidneys ; Male ; Medical sciences ; MIB‐1 ; Middle Aged ; Multivariate Analysis ; Neovascularization, Pathologic ; Nephrology. Urinary tract diseases ; Nuclear Proteins - analysis ; p53 ; Ploidies ; Prognosis ; renal cell carcinoma ; S Phase ; Survival Analysis ; S‐phase fraction ; Tumor Suppressor Protein p53 - metabolism ; Tumors of the urinary system</subject><ispartof>Cancer, 1997-11, Vol.80 (9), p.1768-1775</ispartof><rights>Copyright © 1997 American Cancer Society</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4821-6c2497fab7826885538c5803068b4de5f74a23fcea13ef360658aefe72a6aac63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2064870$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9351546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gelb, Arnold B.</creatorcontrib><creatorcontrib>Sudilovsky, Daniel</creatorcontrib><creatorcontrib>Wu, C. Daniel</creatorcontrib><creatorcontrib>Weiss, Lawrence M.</creatorcontrib><creatorcontrib>Medeiros, L. Jeffrey</creatorcontrib><title>Appraisal of intratumoral microvessel density, MIB‐1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND The prognostic values of intratumoral microvessel density (iMVD), tumor cell proliferation rate, DNA content (ploidy), and p53 protein expression are controversial or have not been well studied in patients with renal cell carcinoma (RCC) confined to the kidney. METHODS A uniform group of 52 clear cell (conventional) RCCs confined to the kidney (classified as T1N0M0 or T2N0M0) were analyzed for iMVD, MIB‐1 score, DNA content, S‐phase fraction, and p53 protein expression by immunohistochemical methods or flow cytometry. iMVD was evaluated in a single area (X200, 1.15 mm2) representative of the highest MVD (neovascular "hot spot") after independently highlighting endothelial cells with antibodies specific for factor VIII‐related antigen (F8/86) and CD31 (JC/70A). The MIB‐1 antibody (Ki‐67 antigen) score was used as a marker for the tumor cell proliferation rate. DNA content and S‐phase fraction were determined by flow cytometry using paraffin embedded tissue. p53 expression was assessed using the D07 antibody. RESULTS The median time of clinical follow‐up was &gt; 9 years. Eleven patients died of disease; the median time to death was 26 months. iMVD counts using antifactor VIII and anti‐CD31 were tightly correlated (correlation coefficient = 0.89). S‐phase fraction was higher in aneuploid tumors than in diploid tumors (mean, 12.4% vs. 4.3%; P = 0.01). Using univariate survival analyses, tumor size (stage classification pT1 vs. PT2; P = 0.01) and nuclear grade (P = 0.04) were associated with shortened survival. No statistically significant differences in survival were found for iMVD, MIB‐1 score, DNA content, S‐phase fraction, or p53 expression. Only two cases strongly expressed p53 protein; both tumors were of high nuclear grade. Using multivariate survival analyses, nuclear grade and tumor size were the only independent prognostic factors (best model P = 0.002). CONCLUSIONS In this study, nuclear grade and tumor size were found to be independent predictors of survival in locally confined clear cell (conventional) RCC, as has been shown previously for locally confined RCC in general. MIB‐1 score, iMVD counts, DNA content, S‐phase fraction, and p53 expression did not contribute additional prognostic information. Cancer 1997; 80:1768‐75. © 1997 American Cancer Society. In a series of 52 clear cell renal cell carcinomas confined to the kidney (classified as pT1N0M0 or pT2N0M0), intratumoral microvessel density, MIB‐1 (Ki‐67) score, S‐phase fraction, DNA content (ploidy), and p53 protein expression did not contribute additional prognostic information. Size (stage classification pT1 vs. pT2) and nuclear grade were found to be the best predictors of survival.</description><subject>Adult</subject><subject>Aged</subject><subject>Antigens, Nuclear</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Carcinoma, Renal Cell - blood supply</subject><subject>Carcinoma, Renal Cell - diagnosis</subject><subject>Cell Division</subject><subject>DNA content</subject><subject>DNA, Neoplasm - metabolism</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>intratumoral microvessel density</subject><subject>Ki-67 Antigen</subject><subject>Kidney</subject><subject>Kidney Neoplasms - blood supply</subject><subject>Kidney Neoplasms - diagnosis</subject><subject>Kidneys</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MIB‐1</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neovascularization, Pathologic</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nuclear Proteins - analysis</subject><subject>p53</subject><subject>Ploidies</subject><subject>Prognosis</subject><subject>renal cell carcinoma</subject><subject>S Phase</subject><subject>Survival Analysis</subject><subject>S‐phase fraction</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Tumors of the urinary system</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkd2KEzEUxwdR1rr6CEIuRHahU_MxmWSqCN1ZPwrrFvwAxYuQZjIamUlmk9S1dz6CL-ML-SRmaO2NgjdJzjn_c_Ln_LJsgeAMQYgfnbxZ1stTBCuWQ1TgE1RVDCGITjmcV08QK_l8vlie5_Vl_Rqhp2QGZ_XqMc7JjWxy6LqZTSCEPKcFeX87uxPClxQyTMlRdlQRimhRTrKfi2Hw0gTZAdcCY6OXcdM7n-LeKO--6hB0Bxptg4nbKXi1PPv1_QcCQTmvp-D8cgGUs1HbOAXSNmCgBAzeRW0s0N8Gn9qNs0CGMfvJuhCNSt80RsnofEhPMMhoUn8A1yZ-Bp1Tsuu249TWWN0Ar20yo3SXDumVsa6Xd7NbreyCvre_j7N3z5-9rV_mF6sXy3pxkauCY5SXChcVa-WacVxyTinhinJIYMnXRaNpywqJSau0RES3pIQl5VK3mmFZSqlKcpw93M1N5q82OkTRmzBakVa7TRCsIgxWFCXhh50wrSwEr1sxeNNLvxUIihGpECNSMcIRIxzxB6ngUFRiRCpEQip2SAURUNQrgQVJs-_vTWzWvW4Ok_cMU_3Bvi5D2l3rpVUmHGQYlgVnMMk-7mTXptPbv_z9394_3e0z5Dc0N847</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>Gelb, Arnold B.</creator><creator>Sudilovsky, Daniel</creator><creator>Wu, C. Daniel</creator><creator>Weiss, Lawrence M.</creator><creator>Medeiros, L. Jeffrey</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19971101</creationdate><title>Appraisal of intratumoral microvessel density, MIB‐1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma</title><author>Gelb, Arnold B. ; Sudilovsky, Daniel ; Wu, C. Daniel ; Weiss, Lawrence M. ; Medeiros, L. Jeffrey</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4821-6c2497fab7826885538c5803068b4de5f74a23fcea13ef360658aefe72a6aac63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antigens, Nuclear</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Carcinoma, Renal Cell - blood supply</topic><topic>Carcinoma, Renal Cell - diagnosis</topic><topic>Cell Division</topic><topic>DNA content</topic><topic>DNA, Neoplasm - metabolism</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>intratumoral microvessel density</topic><topic>Ki-67 Antigen</topic><topic>Kidney</topic><topic>Kidney Neoplasms - blood supply</topic><topic>Kidney Neoplasms - diagnosis</topic><topic>Kidneys</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MIB‐1</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neovascularization, Pathologic</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nuclear Proteins - analysis</topic><topic>p53</topic><topic>Ploidies</topic><topic>Prognosis</topic><topic>renal cell carcinoma</topic><topic>S Phase</topic><topic>Survival Analysis</topic><topic>S‐phase fraction</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Tumors of the urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gelb, Arnold B.</creatorcontrib><creatorcontrib>Sudilovsky, Daniel</creatorcontrib><creatorcontrib>Wu, C. Daniel</creatorcontrib><creatorcontrib>Weiss, Lawrence M.</creatorcontrib><creatorcontrib>Medeiros, L. Jeffrey</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gelb, Arnold B.</au><au>Sudilovsky, Daniel</au><au>Wu, C. Daniel</au><au>Weiss, Lawrence M.</au><au>Medeiros, L. Jeffrey</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Appraisal of intratumoral microvessel density, MIB‐1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>80</volume><issue>9</issue><spage>1768</spage><epage>1775</epage><pages>1768-1775</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>BACKGROUND The prognostic values of intratumoral microvessel density (iMVD), tumor cell proliferation rate, DNA content (ploidy), and p53 protein expression are controversial or have not been well studied in patients with renal cell carcinoma (RCC) confined to the kidney. METHODS A uniform group of 52 clear cell (conventional) RCCs confined to the kidney (classified as T1N0M0 or T2N0M0) were analyzed for iMVD, MIB‐1 score, DNA content, S‐phase fraction, and p53 protein expression by immunohistochemical methods or flow cytometry. iMVD was evaluated in a single area (X200, 1.15 mm2) representative of the highest MVD (neovascular "hot spot") after independently highlighting endothelial cells with antibodies specific for factor VIII‐related antigen (F8/86) and CD31 (JC/70A). The MIB‐1 antibody (Ki‐67 antigen) score was used as a marker for the tumor cell proliferation rate. DNA content and S‐phase fraction were determined by flow cytometry using paraffin embedded tissue. p53 expression was assessed using the D07 antibody. RESULTS The median time of clinical follow‐up was &gt; 9 years. Eleven patients died of disease; the median time to death was 26 months. iMVD counts using antifactor VIII and anti‐CD31 were tightly correlated (correlation coefficient = 0.89). S‐phase fraction was higher in aneuploid tumors than in diploid tumors (mean, 12.4% vs. 4.3%; P = 0.01). Using univariate survival analyses, tumor size (stage classification pT1 vs. PT2; P = 0.01) and nuclear grade (P = 0.04) were associated with shortened survival. No statistically significant differences in survival were found for iMVD, MIB‐1 score, DNA content, S‐phase fraction, or p53 expression. Only two cases strongly expressed p53 protein; both tumors were of high nuclear grade. Using multivariate survival analyses, nuclear grade and tumor size were the only independent prognostic factors (best model P = 0.002). CONCLUSIONS In this study, nuclear grade and tumor size were found to be independent predictors of survival in locally confined clear cell (conventional) RCC, as has been shown previously for locally confined RCC in general. MIB‐1 score, iMVD counts, DNA content, S‐phase fraction, and p53 expression did not contribute additional prognostic information. Cancer 1997; 80:1768‐75. © 1997 American Cancer Society. In a series of 52 clear cell renal cell carcinomas confined to the kidney (classified as pT1N0M0 or pT2N0M0), intratumoral microvessel density, MIB‐1 (Ki‐67) score, S‐phase fraction, DNA content (ploidy), and p53 protein expression did not contribute additional prognostic information. Size (stage classification pT1 vs. pT2) and nuclear grade were found to be the best predictors of survival.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>9351546</pmid><doi>10.1002/(SICI)1097-0142(19971101)80:9&lt;1768::AID-CNCR11&gt;3.0.CO;2-3</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1997-11, Vol.80 (9), p.1768-1775
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_79370951
source Wiley-Blackwell Read & Publish Collection; EZB Electronic Journals Library
subjects Adult
Aged
Antigens, Nuclear
Biological and medical sciences
Biomarkers, Tumor - analysis
Carcinoma, Renal Cell - blood supply
Carcinoma, Renal Cell - diagnosis
Cell Division
DNA content
DNA, Neoplasm - metabolism
Female
Flow Cytometry
Follow-Up Studies
Humans
Immunohistochemistry
intratumoral microvessel density
Ki-67 Antigen
Kidney
Kidney Neoplasms - blood supply
Kidney Neoplasms - diagnosis
Kidneys
Male
Medical sciences
MIB‐1
Middle Aged
Multivariate Analysis
Neovascularization, Pathologic
Nephrology. Urinary tract diseases
Nuclear Proteins - analysis
p53
Ploidies
Prognosis
renal cell carcinoma
S Phase
Survival Analysis
S‐phase fraction
Tumor Suppressor Protein p53 - metabolism
Tumors of the urinary system
title Appraisal of intratumoral microvessel density, MIB‐1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A04%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Appraisal%20of%20intratumoral%20microvessel%20density,%20MIB%E2%80%901%20score,%20DNA%20content,%20and%20p53%20protein%20expression%20as%20prognostic%20indicators%20in%20patients%20with%20locally%20confined%20renal%20cell%20carcinoma&rft.jtitle=Cancer&rft.au=Gelb,%20Arnold%20B.&rft.date=1997-11-01&rft.volume=80&rft.issue=9&rft.spage=1768&rft.epage=1775&rft.pages=1768-1775&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/(SICI)1097-0142(19971101)80:9%3C1768::AID-CNCR11%3E3.0.CO;2-3&rft_dat=%3Cproquest_cross%3E79370951%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4821-6c2497fab7826885538c5803068b4de5f74a23fcea13ef360658aefe72a6aac63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79370951&rft_id=info:pmid/9351546&rfr_iscdi=true